SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Peter Singleton who wrote (21370)5/25/1998 9:29:00 AM
From: Flagrante Delictu  Read Replies (1) | Respond to of 32384
 
Peter, Re: The Takeda dalliance with our Lilly. On the surface, it looks like the temptress "done us wrong". However, Lilly has been plying her wares for a long time in the area of diabetes, earning a substantial fortune doing it. Without further info about the compound & the subset of the diabetes market it seeks to infiltrate, we cannot yet, justifiably, whack our tart "upside the head".
It puts us on notice that she's out there every day selling anything she can, & that she'll link up with anyone.